Gregory Sullivan
2023
In 2023, Gregory Sullivan earned a total compensation of $952K as Chief Medical Officer at Tonix Pharmaceuticals Holding, a 36% decrease compared to previous year.
Compensation breakdown
| Bonus | $181,440 |
|---|---|
| Option Awards | $290,558 |
| Salary | $480,000 |
| Total | $951,998 |
Sullivan received $480K in salary, accounting for 50% of the total pay in 2023.
Sullivan also received $181.4K in bonus and $290.6K in option awards.
Rankings
In 2023, Gregory Sullivan's compensation ranked 1,220th out of 2,739 executives tracked by ExecPay. In other words, Sullivan earned more than 55.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,220 out of 2,739 | 56th |
Division Manufacturing | 732 out of 1,499 | 51st |
Major group Chemicals And Allied Products | 488 out of 843 | 42nd |
Industry group Drugs | 476 out of 809 | 41st |
Industry Pharmaceutical Preparations | 327 out of 578 | 43rd |
Source: SEC filing on April 15, 2024.
Sullivan's colleagues
We found three more compensation records of executives who worked with Gregory Sullivan at Tonix Pharmaceuticals Holding in 2023.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019